Aileron Therapeutics (ALRN)
(Delayed Data from NSDQ)
$3.73 USD
+0.82 (28.18%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $3.83 +0.10 (2.68%) 7:58 PM ET
4-Sell of 5 4
D Value F Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
10/11/2024
Time: -- |
9/2024 | $-0.25 | 0.00% |
Earnings Summary
For their last quarter, Aileron Therapeutics (ALRN) reported earnings of -$0.45 per share, missing the Zacks Consensus Estimate of -$0.25 per share. This reflects a negative earnings surprise of 80.00%. Look out for ALRN's next earnings release expected on October 11, 2024. For the next earning release, we expect the company to report earnings of -$0.25 per share, reflecting a year-over-year increase of 37.5%.
Earnings History
Price & Consensus
Zacks News for ALRN
Down -36.29% in 4 Weeks, Here's Why Aileron Therapeutics (ALRN) Looks Ripe for a Turnaround
ALRN: What are Zacks experts saying now?
Zacks Private Portfolio Services